Dassault Systemes raises funds for healthcare software firm BioSerenity

Tuesday, 18 Jun 2019 

June 18 (Reuters) - Dassault Systemes SE ::* BioSerenity, developer of solutions dedicated to personalized patient continuous care, raises €65 million, including €50 million in Series B equity financing led by Dassault Systèmes.* Investment will allow BioSerenity to accelerate the development of sensor-equipped wearables and associated telehealth solutions in the fields of cardiology, neurology and sleep disorders.